✦ LIBER ✦

Sensitivity analyses of the primary efficacy endpoint in a randomized-withdrawal phase 3 trial of tapentadol extended release (ER) in patients with painful diabetic peripheral neuropathy (DPN)

✍ Scribed by Etropolski, M.; Steup, A.; Shapiro, D.Y.; Okamoto, A.; Haeussler, J.

Book ID: 121955022
Publisher: Canadian Diabetes Association
Year: 2009
Tongue: English
Weight: 448 KB
Volume: 33
Category: Article
ISSN: 1499-2671
DOI: 10.1016/S1499-2671(09)33156-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and tolerability of tapentadol

Efficacy and tolerability of tapentadol extended release (ER) in patients with chronic, painful diabetic peripheral neuropathy (DPN): results of a phase 3, randomized-withdrawal, placebo-controlled study

✍ A. Vinik; D. Shapiro; C. Rauschkolb-Löffler; B. Lange; K. Karcher; D. Pennett; M 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 38 KB

Health-related outcomes associated with

✍ Etropolski, M.; Kleinert, R.; Shapiro, D.Y.; Okamoto, A.; Lange, R.; Rauschkolb, 📂 Article 📅 2009 🏛 Canadian Diabetes Association 🌐 English ⚖ 436 KB

Health status (EuroQol-5 Dimension [EQ-5

Health status (EuroQol-5 Dimension [EQ-5D]) in patients with painful diabetic peripheral neuropathy (DPN) treated with tapentadol extended release (ER): results of a randomized-withdrawal phase 3 study

✍ Okamoto, A.; Shapiro, D.Y.; Lange, B.; Lange, R.; Etropolski, M. 📂 Article 📅 2009 🏛 Canadian Diabetes Association 🌐 English ⚖ 435 KB

Safety and efficacy of tapentadol ER in

Safety and efficacy of tapentadol ER in patients with painful diabetic peripheral neuropathy: results of a randomized-withdrawal, placebo-controlled trial

✍ Schwartz, Sherwyn; Etropolski, Mila; Shapiro, Douglas Y.; Okamoto, Akiko; Lange, 📂 Article 📅 2010 🏛 Informa plc 🌐 English ⚖ 364 KB

A Randomized Withdrawal, Placebo-Control

A Randomized Withdrawal, Placebo-Controlled Study Evaluating the Efficacy and Tolerability of Tapentadol Extended Release in Patients With Chronic Painful Diabetic Peripheral Neuropathy

✍ Vinik, Aaron I.; Shapiro, Douglas Y.; Rauschkolb, Christine; Lange, Bernd; Karch 📂 Article 📅 2014 🏛 American Diabetes Association 🌐 English ⚖ 878 KB

(387) Sensitivity analyses of the primar

(387) Sensitivity analyses of the primary efficacy endpoint in a phase 2 randomized, placebo-controlled study of gabapentin enacarbil (GEn) in patients with neuropathic pain associated with postherpetic neuralgia (PHN)

✍ Calkins, A.; Gudin, J.; Gidal, B.; Jaros, M.; Kim, R.; Shang, G. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 92 KB